Physician profile
Timoteo Cabrera
NPI 1144295064
$4,087.86
in general payments reported to CMS, 2019-2025
19 companies · $695 in 2025
The $695 reported for 2025 was more than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $424 · 2020: $121 · 2021: $727 · 2022: $715 · 2023: $535 · 2024: $871 · 2025: $695.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,100.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,351.71 | 2021-2025 | Ellipsys Vascular Access System |
| Astrazeneca Pharmaceuticals Lp | $841.71 | 2021-2025 | Lokelma, Farxiga |
| Bard Peripheral Vascular, INC. | $312.39 | 2019-2024 | Covera |
| Amgen INC. | $242.39 | 2023-2025 | Krystexxa, Tavneos |
| Aurinia Pharma U.S., INC. | $209.61 | 2021-2024 | Lupkynis |
| Venturemed Group, INC. | $178.36 | 2024 | Flex Vessel Prep System |
| Otsuka America Pharmaceutical, INC. | $126.67 | 2019 | |
| Glaxosmithkline, LLC. | $124.99 | 2021 | |
| Lilly USA, LLC | $124.99 | 2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $124.98 | 2025 | |
| Mallinckrodt Hospital Products INC. | $117.41 | 2022 | |
| Opko Pharmaceuticals, LLC | $89.21 | 2019 | |
| Mozarc Medical US LLC | $73.73 | 2023-2025 | Chameleon |
| Covidien Lp | $60.58 | 2019-2020 | |
| Philips North America LLC | $33.29 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nxstage Medical, INC. | $26.70 | 2022 | |
| Alexion Pharmaceuticals, INC. | $17.88 | 2021 | |
| Avenu Medical INC. | $17.62 | 2020 | |
| Biotronik INC. | $13.64 | 2024 | Pulsar-18 T3, Passeo-18 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timoteo Cabrera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.